UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 946

Sortiert nach

Phase II, two-stage, single-arm trial of the histone deacetylase inhibitor (HDACi) romidepsin in metastatic castration-resistant prostate cancer (CRPC)

Annals of oncology, 2010-01, Vol.21 (1), p.109-113

2010

Volltextzugriff (PDF)

Long-term Survival and Biomarker Correlates of Tasquinimod Efficacy in a Multicenter Randomized Study of Men with Minimally Symptomatic Metastatic Castration-Resistant Prostate Cancer

Clinical cancer research, 2013-12, Vol.19 (24), p.6891-6901

2013

Volltextzugriff (PDF)

MVA-MUC1-IL2 vaccine immunotherapy (TG4010) improves PSA doubling time in patients with prostate cancer with biochemical failure

Investigational new drugs, 2009-08, Vol.27 (4), p.379-386

2009

Volltextzugriff (PDF)

Novel approaches and future directions in castration-resistant prostate cancer

Annals of oncology, 2011-09, Vol.22 (9), p.1948-1957

2011

Volltextzugriff (PDF)

Phase II study of single-agent gemcitabine in previously untreated patients with metastatic urothelial cancer

Journal of clinical oncology, 1997-11, Vol.15 (11), p.3394-3398

1997

Volltextzugriff (PDF)

A phase I study of sirolimus and bevacizumab in patients with advanced malignancies

European journal of cancer (1990), 2011-07, Vol.47 (10), p.1484-1489

2011

Volltextzugriff (PDF)

Estimation of Renal Cell Carcinoma Treatment Effects From Disease Progression Modeling

Clinical pharmacology and therapeutics, 2013-04, Vol.93 (4), p.345-351

2013

Volltextzugriff (PDF)

A phase I study of antisense oligonucleotide GTI-2040 given by continuous intravenous infusion in patients with advanced solid tumors

Annals of oncology, 2005-06, Vol.16 (6), p.958-965

2005

Volltextzugriff (PDF)

Depletion of normal B cells with rituximab as an adjunct to IL-2 therapy for renal cell carcinoma and melanoma

Annals of oncology, 2004-07, Vol.15 (7), p.1109-1114

2004

Volltextzugriff (PDF)

Kidney cancer

The Lancet (British edition), 1998-11, Vol.352 (9141), p.1691-1696

1998

Volltextzugriff (PDF)

A multicenter, open-label, randomized, phase II study of cediranib with or without lenalidomide in iodine 131-refractory differentiated thyroid cancer

Annals of oncology, 2023-08, Vol.34 (8), p.714-722

2023

Volltextzugriff (PDF)

Inflammation of actinic keratoses subsequent to therapy with sorafenib, a multitargeted tyrosine-kinase inhibitor

Clinical and experimental dermatology, 2006-11, Vol.31 (6), p.783-785

2006

Volltextzugriff (PDF)

Flavopiridol, A Novel Cyclin-Dependent Kinase Inhibitor, in Metastatic Renal Cancer: A University of Chicago Phase II Consortium Study

Journal of clinical oncology, 2000-01, Vol.18 (2), p.371-375

2000

Volltextzugriff (PDF)

Mitogen-activated protein kinase kinase 4/stress-activated protein/erk kinase 1 (MKK4/SEK1), a prostate Cancer metastasis suppressor gene encoded by human chromosome 17

Cancer research (Chicago, Ill.), 1999-11, Vol.59 (21), p.5483-5487

1999

Volltextzugriff (PDF)

Phase II Trial of Weekly Intravenous Gemcitabine With Continuous Infusion Fluorouracil in Patients With Metastatic Renal Cell Cancer

Journal of clinical oncology, 2000-06, Vol.18 (12), p.2419-2426

2000

Volltextzugriff (PDF)

Multi-Institutional Study of the Angiogenesis Inhibitor TNP-470 in Metastatic Renal Carcinoma

Journal of clinical oncology, 1999-08, Vol.17 (8), p.2541-2545

1999

Volltextzugriff (PDF)

Doxorubicin plus the IGF-1R antibody cixutumumab in soft tissue sarcoma: a phase I study using the TITE-CRM model

Annals of oncology, 2019-08, Vol.30 (8), p.1405-1405

2019

Volltextzugriff (PDF)

Long-term follow-up of nonmyeloablative allogeneic stem cell transplantation for renal cell carcinoma: The University of Chicago Experience

Bone marrow transplantation (Basingstoke), 2005-02, Vol.35 (3), p.253-260

2005

Volltextzugriff (PDF)

Use of a New Tumor Marker, Urinary NMP22, in the Detection of Occult or Rapidly Recurring Transitional Cell Carcinoma of the Urinary Tract Following Surgical Treatment

The Journal of urology, 1996-08, Vol.156 (2), p.363-367

1996

Volltextzugriff (PDF)

Doxorubicin plus the IGF-1R antibody cixutumumab in soft tissue sarcoma: a phase I study using the TITE-CRM model

Annals of oncology, 2015-07, Vol.26 (7), p.1459-1464

2015

Volltextzugriff (PDF)

Detection of Bladder Cancer Using a Novel Nuclear Matrix Protein, BLCA-4

Clinical cancer research, 2000-07, Vol.6 (7), p.2618-2625

2000

Volltextzugriff (PDF)

Development of target-based antineoplastic agents

Investigational new drugs, 2000-02, Vol.18 (1), p.7-16

2000

Volltextzugriff (PDF)

Patient Perceptions of Care as Influenced by a Large Institutional Pharmacogenomic Implementation Program

Clinical pharmacology and therapeutics, 2017-07, Vol.102 (1), p.106-114

2017

Volltextzugriff (PDF)

Elevated p16 at senescence and loss of p16 at immortalization in human papillomavirus 16 E6, but not E7, transformed human uroepithelial cells

Cancer research (Chicago, Ill.), 1996-07, Vol.56 (13), p.2886-2890

1996

Volltextzugriff (PDF)

Flavopiridol Metabolism in Cancer Patients Is Associated with the Occurrence of Diarrhea

Clinical cancer research, 2000-09, Vol.6 (9), p.3400-3405

2000

Volltextzugriff (PDF)

1 – 25 von 946

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(807)
Mit Volltextzugriff
(813)

Publikationsform

1 weiteren anzeigen...

Weniger anzeigen...

Sprache

4 weitere anzeigen...

Weniger anzeigen...

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Kollektion

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

Journal Of Clinical Oncology
(127)
Astronomy And Astrophysics
(41)
Cancer
(23)
Clinical Cancer Research
(21)
Astronomy & Astrophysics
(19)
Annals Of Oncology
(15)
Mycotaxon
(13)
The Journal Of Urology
(13)
Cancer Research
(11)
Bioorganic & Medicinal Chemistry Letters
(10)

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(1)
... seit 90 Tagen
(6)

Menü

Weitere Dienste

Einstellungen

Phase II, two-stage, single-arm trial of the histone deacetylase inhibitor (HDACi) romidepsin in metastatic castration-resistant prostate cancer (CRPC)

Long-term Survival and Biomarker Correlates of Tasquinimod Efficacy in a Multicenter Randomized Study of Men with Minimally Symptomatic Metastatic Castration-Resistant Prostate Cancer

MVA-MUC1-IL2 vaccine immunotherapy (TG4010) improves PSA doubling time in patients with prostate cancer with biochemical failure

Novel approaches and future directions in castration-resistant prostate cancer

Phase II study of single-agent gemcitabine in previously untreated patients with metastatic urothelial cancer

A phase I study of sirolimus and bevacizumab in patients with advanced malignancies

Estimation of Renal Cell Carcinoma Treatment Effects From Disease Progression Modeling

A phase I study of antisense oligonucleotide GTI-2040 given by continuous intravenous infusion in patients with advanced solid tumors

Depletion of normal B cells with rituximab as an adjunct to IL-2 therapy for renal cell carcinoma and melanoma

Kidney cancer

A multicenter, open-label, randomized, phase II study of cediranib with or without lenalidomide in iodine 131-refractory differentiated thyroid cancer

Inflammation of actinic keratoses subsequent to therapy with sorafenib, a multitargeted tyrosine-kinase inhibitor

Flavopiridol, A Novel Cyclin-Dependent Kinase Inhibitor, in Metastatic Renal Cancer: A University of Chicago Phase II Consortium Study

Mitogen-activated protein kinase kinase 4/stress-activated protein/erk kinase 1 (MKK4/SEK1), a prostate Cancer metastasis suppressor gene encoded by human chromosome 17

Phase II Trial of Weekly Intravenous Gemcitabine With Continuous Infusion Fluorouracil in Patients With Metastatic Renal Cell Cancer

Multi-Institutional Study of the Angiogenesis Inhibitor TNP-470 in Metastatic Renal Carcinoma

Doxorubicin plus the IGF-1R antibody cixutumumab in soft tissue sarcoma: a phase I study using the TITE-CRM model

Long-term follow-up of nonmyeloablative allogeneic stem cell transplantation for renal cell carcinoma: The University of Chicago Experience

Use of a New Tumor Marker, Urinary NMP22, in the Detection of Occult or Rapidly Recurring Transitional Cell Carcinoma of the Urinary Tract Following Surgical Treatment

Doxorubicin plus the IGF-1R antibody cixutumumab in soft tissue sarcoma: a phase I study using the TITE-CRM model

Detection of Bladder Cancer Using a Novel Nuclear Matrix Protein, BLCA-4

Development of target-based antineoplastic agents

Patient Perceptions of Care as Influenced by a Large Institutional Pharmacogenomic Implementation Program

Elevated p16 at senescence and loss of p16 at immortalization in human papillomavirus 16 E6, but not E7, transformed human uroepithelial cells

Flavopiridol Metabolism in Cancer Patients Is Associated with the Occurrence of Diarrhea

Suchergebnisse filtern